Dexcel Pharma For Profit
At Dexcel Pharma we develop, commercialize, manufacture, and invest in pharmaceutical products.
Investment Stage:
Undisclosed
Founded Date:
1968-01-01
Investor Type:
Undisclosed
Estimated Revenue:
$50M to $100M
Employee Number:
501-1000
Number Of Exists:
Undisclosed
Industry:
End-to-End Drug Development
Headquarters:
Jerusalem, Yerushalayim, Israel
Funding Status:
N/A